ARMEN GARO H 4
4 · AGENUS INC · Filed Apr 21, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo H. Armen Receives 3,403 Shares
What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), received 3,403 shares of common stock on April 17, 2026 as payment of salary in lieu of cash. The shares were issued at $4.79 per share (closing price on April 17), for a total value of approximately $16,300, and are reported as fully vested on the date of issuance.
Key Details
- Transaction date: April 17, 2026; Form 4 filed April 21, 2026. (The filing was four days after the transaction; Form 4s are typically due within two business days, so this appears to be late.)
- Price/value: $4.79 per share; total reported value ≈ $16,300.
- Shares received: 3,403 (reported as an award/grant/acquisition — code A).
- Shares owned after transaction: Not specified in the filing.
- Notable footnotes:
- Shares were issued as salary with Compensation Committee approval and represent the net amount of pay for the period ending April 17, 2026; issued under the 2019 Equity Incentive Plan and fully vested on issuance.
- Shares are held in Dr. Armen’s IRA accounts.
- Dr. Armen is trustee and has investment authority for a GRAT holding 23,950 shares and is a general partner in Pixie Partners, which owns 5,000 shares; he disclaims beneficial ownership to the extent of his pecuniary interest in Pixie.
Context
This was compensation paid in stock (an award), not an open-market purchase or sale — a routine way for companies to pay executives and generally not a direct market-timing signal. The filing notes the transaction is payroll-related and fully vested at issuance.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-04-17$4.79/sh+3,403$16,300→ 342,550 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending April 17, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F2]$4.79 is the closing price of our Common Stock on April 17, 2026, the last trading day for the payroll date for the pay period ending April 17, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.